Surgalign Holdings, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Surgalign Holdings, Inc. (NASDAQ: SRGA) announced on October 6, 2022, the granting of 10,081 restricted stock units to two new employees as an employment inducement. This award, granted under the 2021 Inducement Plan, vests over three years, with one-third vesting on the first anniversary and the remainder quarterly thereafter. This move, approved by the independent Compensation Committee, aims to attract talent while complying with Nasdaq regulations. Surgalign focuses on advancing digital health technologies in surgery, marketing products across the U.S. and over 50 countries.
- Inducement to attract new talent through awarded restricted stock units.
- Compliance with Nasdaq regulations via the approval of the independent Compensation Committee.
- None.
DEERFIELD, Ill., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that it has granted restricted stock unit awards to two (2) employees, none of whom was an executive officer, as an inducement for them to accept employment with Surgalign, and representing the right to receive, in the aggregate, up to 10,081 shares of Surgalign common stock. The award was granted on October 03, 2022 and it was made under the Surgalign Holdings, Inc. 2021 Inducement Plan. One-third of the restricted stock units vest on the first anniversary of the date of grant, and one-eighth of the remaining restricted stock units vest on each subsequent quarterly anniversary of the date of grant, such that the award will be fully vested on the third anniversary of the date of grant, subject to continued employment through the applicable vesting date.
The awards were approved by the independent Compensation Committee of the Board of Directors of Surgalign Holdings and were granted to the new employees as an inducement material to their acceptance of employment with Surgalign pursuant to Nasdaq rules.
About Surgalign Holdings, Inc.
Surgalign Holdings, Inc. is a global medical technology company committed to the promise of digital health and is building out its digital surgery platform to drive transformation across the surgical landscape. Uniquely aligned and resourced to advance the standard of care, the company is building technologies surgeons will look to for what is truly possible for their patients. Surgalign is focused on bringing surgeons solutions that predictably deliver superior clinical and economic outcomes. Surgalign markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors. Surgalign is headquartered in Deerfield, IL, with commercial, innovation and design centers in San Diego, CA, Warsaw and Poznan, Poland and Wurmlingen, Germany. Learn more at www.surgalign.com and connect on LinkedIn and Twitter.
Forward Looking Statement
This press release contains forward-looking statements based on management’s current expectations, estimates and projections about our industry, our management's beliefs and certain assumptions made by our management. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in public filings with the U.S. Securities and Exchange Commission (SEC). Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the company's SEC filings may be obtained by contacting the company or the SEC or by visiting Surgalign's website at www.surgalign.com or the SEC's website at www.sec.gov.
| Investor and Media Contact: | Surgalign Contact: |
| Glenn Wiener | Kristine Simmons |
| gwiener@gwcco.com | ksimmons@surgalign.com |
| + 1 917 887 8434 | +1 619 206 4648 |
FAQ
What restricted stock units were granted by Surgalign Holdings on October 6, 2022?
What is the vesting schedule for the restricted stock units granted by SRGA?
Who approved the restricted stock unit awards at Surgalign Holdings?
Under which plan were the restricted stock units granted by Surgalign?
What is the purpose of granting restricted stock units at Surgalign?
